C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer-Reference-Cited by-同舟云学术

C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer

Published:2015-10-29 Issue:3 Volume:5 Page:e1105428
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Rapp Moritz,Grassmann Simon,Chaloupka Michael,Layritz Patrick,Kruger Stephan,Ormanns Steffen,Rataj Felicitas,Janssen Klaus-Peter,Endres Stefan,Anz David,Kobold Sebastian

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2015.1105428

Reference48 articles.

1. Raising the Bar: The Curative Potential of Human Cancer Immunotherapy

2. Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology

3. Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

4. Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma

5. Adoptive Transfer of Cloned Melanoma-Reactive T Lymphocytes for the Treatment of Patients with Metastatic Melanoma

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors;Seminars in Immunopathology;2024-07-25

2. Construction and validation of a novel immunological model to predict prognosis in pancreatic ductal adenocarcinoma;International Immunopharmacology;2024-06

3. Targeting Other Promising Cell Surface Receptors;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Engineering strategies to optimise adoptive cell therapy in ovarian cancer;Cancer Treatment Reviews;2023-12

5. DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies;Frontiers in Immunology;2023-11-28